Scarica l'app Stockscreener
11.04
1.27%
-0.01
Precedente Chiudi:
$11.05
Aprire:
$11
Volume 24 ore:
8,039
Relative Volume:
0.10
Capitalizzazione di mercato:
$178.59M
Reddito:
-
Utile/perdita netta:
$-33.82M
Rapporto P/E:
-0.4314
EPS:
-25.5891
Flusso di cassa netto:
$-66.04M
1 W Prestazione:
-4.84%
1M Prestazione:
-1.09%
6M Prestazione:
+31.29%
1 anno Prestazione:
+115.61%
Intervallo 1D:
$10.70
$11.00
Intervallo di 1 settimana:
$10.70
$11.62
Portata 52W:
$4.05
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Nome
Elicio Therapeutics Inc
Settore
Industria
Telefono
(857) 209-0050
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Confronta ELTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
10.93 | 181.19M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.31 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.99 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.96 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
716.92 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.52 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
Using R and stats models for Elicio Therapeutics Inc. forecasting2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Elicio Therapeutics Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
How moving averages guide Elicio Therapeutics Inc. tradingJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
What technical models suggest about Elicio Therapeutics Inc.’s comeback2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
Is Elicio Therapeutics Inc. still worth holding after the dip2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
How to use a screener to detect Elicio Therapeutics Inc. breakouts2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
Is Elicio Therapeutics Inc. building a consolidation baseWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
Multi factor analysis applied to Elicio Therapeutics Inc.IPO Watch & Daily Profit Maximizing Tips - newser.com
How sentiment analysis helps forecast Elicio Therapeutics Inc.Quarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Elicio Therapeutics Hits New 52-Week High of $12.61 - Markets Mojo
ETF Watch: Can Elicio Therapeutics Inc lead its sector in growth2025 Short Interest & Community Verified Swing Trade Signals - خودرو بانک
Will earnings trigger a reversal in Elicio Therapeutics Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Retail Surge: Can TOON expand into new marketsJuly 2025 Spike Watch & Detailed Earnings Play Alerts - khodrobank.com
Technical analysis overview for Elicio Therapeutics Inc. stockMarket Risk Report & Smart Investment Allocation Tips - newser.com
Top chart patterns to watch in Elicio Therapeutics Inc.July 2025 Recap & AI Based Trade Execution Alerts - newser.com
Smart Money: Is Elicio Therapeutics Inc stock suitable for long term investingWatch List & Free Weekly Watchlist of Top Performers - خودرو بانک
Elicio Therapeutics reports inducement grants - TipRanks
Is Elicio Therapeutics Inc. showing signs of accumulationJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
Published on: 2025-09-18 22:03:11 - newser.com
Technical signs of recovery in Elicio Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com
Rate Hike: Whats next for Elicio Therapeutics Inc stockTrade Performance Summary & High Accuracy Swing Trade Signals - خودرو بانک
Is now a turning point for Elicio Therapeutics Inc.Weekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is it time to cut losses on Elicio Therapeutics Inc.July 2025 Retail & Accurate Trade Setup Notifications - newser.com
Elicio Therapeutics : AMPLIFY-7P Phase 2 Immunogenicity Data - MarketScreener
Elicio Therapeutics Reports Inducement Grants - GlobeNewswire
Cancer Vaccine Developer Elicio Therapeutics Awards Stock Options to Expand Research Team - Stock Titan
Risk Check: Does Elicio Therapeutics Inc. have declining or rising EPSMarket Sentiment Review & Fast Exit and Entry Trade Guides - خودرو بانک
Retail Surge: Is Elicio Therapeutics Inc. impacted by rising rates - khodrobank.com
Will Elicio Therapeutics Inc. stock recover after recent dropTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Elicio Therapeutics Announces Promising Phase 2 Vaccine Results - TipRanks
Elicio’s cancer vaccine ELI-002 shows strong immune response in 99% of patients - Investing.com Canada
Elicio Therapeutics Reports 99% mKRAS-Specific T Cell Response in Phase 2 AMPLIFY-7P Trial of ELI-002 Vaccine - Quiver Quantitative
Elicio Therapeutics Reports ELI-002 7P Achieved Robust - GlobeNewswire
145-fold Immune Response Boost: Elicio's Cancer Vaccine Shows Remarkable 99% Success Rate in Phase 2 Study - Stock Titan
Aug Action: Can Elicio Therapeutics Inc. stock double in the next yearJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - خودرو بانک
What are the future prospects of Elicio Therapeutics IncTrade Volume Summary & Technical Pattern Alert System - خودرو بانک
Momentum Shift: What is Elicio Therapeutics Inc.’s book value per shareEarnings Overview Summary & Verified Momentum Stock Watchlist - خودرو بانک
Earnings Update: How do insiders feel about Elicio Therapeutics IncMarket Performance Report & Consistent Growth Equity Picks - خودرو بانک
Published on: 2025-09-15 22:50:51 - newser.com
Growth Review: What are the future prospects of Elicio Therapeutics IncMarket Volume Report & High Conviction Investment Ideas - خودرو بانک
Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):